Cargando…

Alterations in the intestinal microbiota associated with active tuberculosis and latent tuberculosis infection()

OBJECTIVES: To study the characteristics of intestinal microbiota at different stages of Mycobacterium tuberculosis infection. METHODS: Fecal samples of 19 active tuberculosis (ATB) patients, 21 latent tuberculosis infection (LTBI) individuals, and 20 healthy controls (HC) were collected. Gut microb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yuan, Tang, Jinhua, Cai, Zheng, Qi, Yun, Jiang, Shen, Ma, Tingting, Yue, Ying, Huang, Fang, Yang, Han, Ma, Yueyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692819/ https://www.ncbi.nlm.nih.gov/pubmed/38045157 http://dx.doi.org/10.1016/j.heliyon.2023.e22124

Ejemplares similares

Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-γ release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis
por: Tang, Jinhua, et al.
Publicado: (2021)

Development of diagnostic algorithm using machine learning for distinguishing between active tuberculosis and latent tuberculosis infection
por: Luo, Ying, et al.
Publicado: (2022)

Behçet’s disease with latent Mycobacterium tuberculosis infection
por: Shen, Yan, et al.
Publicado: (2020)

Tuberculosis Infection and Latent Tuberculosis
por: Lee, Seung Heon
Publicado: (2016)

Latent tuberculosis
por: Koul, Ajaz Nabi
Publicado: (2016)

Combination of prealbumin and tuberculosis‐specific antigen/phytohemagglutinin ratio for discriminating active tuberculosis from latent tuberculosis infection
por: Luo, Ying, et al.
Publicado: (2020)

Treatment of Latent Tuberculosis Infection
por: Tang, Patrick, et al.
Publicado: (2017)

Combination of HLA-DR on Mycobacterium tuberculosis-Specific Cells and Tuberculosis Antigen/Phytohemagglutinin Ratio for Discriminating Active Tuberculosis From Latent Tuberculosis Infection
por: Luo, Ying, et al.
Publicado: (2021)

Development of Disseminated Tuberculosis with Intestinal Involvement due to Adalimumab Administration Despite Latent Tuberculosis Treatment
por: Ikuta, Kozo, et al.
Publicado: (2019)

Alterations of Gut Microbiota in Patients With Intestinal Tuberculosis That Different From Crohn’s Disease
por: He, Cong, et al.
Publicado: (2021)

Activation Phenotype of Mycobacterium tuberculosis-Specific CD4(+) T Cells Promoting the Discrimination Between Active Tuberculosis and Latent Tuberculosis Infection
por: Luo, Ying, et al.
Publicado: (2021)

The Treatment of Latent Tuberculosis
Publicado: (1905)

Latent tuberculosis infection and tuberculosis in children and adolescents
por: Ishikawa, Cassia Satsuki, et al.
Publicado: (2018)

Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis
por: Wu, Chunli, et al.
Publicado: (2023)

Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection
por: Feria, Manuel G, et al.
Publicado: (2022)

Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection
por: Xiao, Jia-ni, et al.
Publicado: (2017)

Gut microbiota composition can reflect immune responses of latent tuberculosis infection in patients with poorly controlled diabetes
por: Huang, Hung-Ling, et al.
Publicado: (2023)

Screening for latent tuberculosis: the way forward for tuberculosis elimination
por: Petersen, Eskild, et al.
Publicado: (2022)

Alteration in the Gut Microbiota Provokes Susceptibility to Tuberculosis
por: Khan, Nargis, et al.
Publicado: (2016)

The ongoing challenge of latent tuberculosis
por: Esmail, H., et al.
Publicado: (2014)

Immune Subtyping in Latent Tuberculosis
por: Banerjee, Ushashi, et al.
Publicado: (2021)

Latent Tuberculosis in India: An Overview
por: Vishwakarma, Deepak, et al.
Publicado: (2023)

Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection
por: Luo, Ying, et al.
Publicado: (2021)

Anatomic and Cellular Niches for Mycobacterium tuberculosis in Latent Tuberculosis Infection
por: Mayito, Jonathan, et al.
Publicado: (2019)

Guidelines on controlling latent tuberculosis infection to support tuberculosis elimination
por: Godoy, P
Publicado: (2021)

Prevotella Induces the Production of Th17 Cells in the Colon of Mice
por: Huang, Yuan, et al.
Publicado: (2020)

Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis
por: Qiu, Xia, et al.
Publicado: (2019)

The blood transcriptional signature for active and latent tuberculosis
por: Deng, Min, et al.
Publicado: (2019)

Algorithms for Screening for Active Tuberculosis among Individuals with Latent Tuberculosis Infection in a Rural Community in China
por: Xin, Henan, et al.
Publicado: (2022)

Safety of Biologics for Psoriatic Patients with Latent Tuberculosis
por: Yuan, Liyan, et al.
Publicado: (2023)

An outbreak of pulmonary tuberculosis and a follow-up investigation of latent tuberculosis in a high school in an eastern city in China, 2016–2019
por: Fang, Yirong, et al.
Publicado: (2021)

Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis
por: Lee, Meng-Rui, et al.
Publicado: (2017)

Small RNA Profiles of Serum Exosomes Derived From Individuals With Latent and Active Tuberculosis
por: Lyu, Lingna, et al.
Publicado: (2019)

Prevalence of latent tuberculosis infection and incidence of active tuberculosis in school close contacts in Shanghai, China: Baseline and follow-up results of a prospective cohort study
por: Xiao, Xiao, et al.
Publicado: (2022)

Host transcription in active and latent tuberculosis
por: Fortune, Sarah M, et al.
Publicado: (2010)

Diagnosis and Treatment of Latent Tuberculosis Infection
por: Lee, Seung Heon
Publicado: (2015)

Latent Tuberculosis Infection - Diagnosis and Treatment
por: Ilievska-Poposka, Biljana, et al.
Publicado: (2018)

Risk for latent and active tuberculosis in Germany
por: Herzmann, Christian, et al.
Publicado: (2016)

Latent tuberculosis and the use of immunomodulatory agents
por: Aguiar, Fábio Silva, et al.
Publicado: (2019)

Latent Tuberculosis: Two Centuries of Confusion
por: Behr, Marcel A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ui5mrjjcde2jcbjqfkpoujootb